account_id none on file
legal_name Skye Bioscience, Inc.
ticker SKYE
cik 1516551
domain skyebioscience.com
linkedin_company_url https://www.linkedin.com/company/skyebioscience/
entry_point_account_id none on file
name Skye Bioscience Inc.
exchange Nasdaq
sector Health Care
hq San Diego, CA, United States
sector index/company/sector/health-care/
calls 1 filings 0 executives 8 family 0
why_nownone on file
calls
The remainder of the increase resulted from increases in employee benefits, travel, and consulting fees driven by increases in headcount.
Nov 7, 2024 / receipt, needs a key / Caitlin Arsenault, CFO | earnings call 2024-11-07 | transcript 02d85643-e877-41dd-80f9-0b1442f79cec | chars 10090-10227 | segment 10
filingsnone on file
executives
| Avtar Dhillon | Executive Chairman of the Board | - | receipt |
| Brian S. Murphy | Chief Medical Officer | - | receipt |
| Caitlin Arsenault | CFO | - | receipt |
| Douglas S. Ingram | director | - | receipt |
| John P. Sharp | Chief Financial Officer | - | receipt |
| Puneet Dhillon | CEO | - | receipt |
| Punit Dhillon | Chairman of the Board | - | receipt |
| Thomas A. George | director | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
| 2026-04-03 | Chief Financial Officer, appointed | sec_8k |
| 2019-12-23 | Chairman of the Board, appointed | sec_8k |
| 2018-10-12 | Executive Chairman of the Board, appointed | sec_8k |
| 2015-08-25 | Chief Medical Officer, appointed | sec_8k |
| 2015-06-04 | director, appointed | sec_8k |
| 2015-01-12 | director, appointed | sec_8k |
mcp_package_hint
slug skye-bioscience-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$